ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES

ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES

A certain success in the treatment of bronchial asthma is associated with the introduction of monoclonal antibodies into the treatment process. They made it possible to improve the control of the disease. A number of original genetically engineered biological drugs, such as benralizumab, reslizumab,...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. S. Krysanova, E. D. Ermolaeva, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2021-08-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	bronchial asthma biosimilar omalizumab dupilumab costs pharmacoeconomic analysis
Online Access:	https://www.pharmpharm.ru/jour/article/view/864
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data
by: A. S. Kolbin, et al.
Published: (2016-11-01)

Drug survival of omalizumab in atopic asthma: Impact of clinical and genetic variables
by: Susana Rojo-Tolosa, et al.
Published: (2025-12-01)

CLINICAL EFFICIENCY AND THE PHARMACOECONOMIC ANALYSIS OF ALLERGEN IMMUNOTHERAPY AT PATIENTS WITH MILD AND MODERATE ALLERGIC BRONCHIAL ASTHMA
by: Elena Albertovna Sobko, et al.
Published: (2015-09-01)

Genetically Engineered Biologic Drugs in Management of Children with Bronchial Asthma
by: Svetlana V. Zaytseva, et al.
Published: (2021-12-01)

Cost-effectiveness of omalizumab in real world uncontrolled allergic asthma patients
by: A. Arrobas, et al.
Published: (2021-03-01)

Severe case of bullous pemphigoid associated with nivolumab responsive to combination therapy with dupilumab and omalizumab
by: Liana Victory, MB, BCh, BAO, MRCPI, et al.
Published: (2025-03-01)

Achievement of Control of Severe Bronchial Asthma When Using Dupilumab
by: O. V. Kazmerchuk, et al.
Published: (2024-11-01)

PRIMARY RESULTS OF LONG-TERM DYNAMIC MONITORING OF CHILDREN WITH BRONCHIAL ASTHMA OF UNCONTROLLED SEVERE PERSISTENT COURSE
by: L. S. Namazova-Baranova, et al.
Published: (2017-02-01)

Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma
by: S. V. Nedogoda, et al.
Published: (2024-02-01)

Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region
by: A. D. Ermolaeva, et al.
Published: (2021-07-01)

Four-week IgE/baseline IgE ratio combined with tryptase predicts clinical outcome in omalizumab-treated children with moderate-to-severe asthma
by: Lu Min, et al.
Published: (2025-05-01)

IMMUNOLOGICAL MARKERS OF UNCONTROLLED ATOPIC BRONCHIAL ASTHMA IN CHILDREN
by: M. V. Smolnikova, et al.
Published: (2017-08-01)

Case Report: Omalizumab combined with voriconazole for the treatment of ABPA complicating IPA: a case report
by: Tingrui Zhao, et al.
Published: (2025-07-01)

Comparative Analysis of ICS Combined with LABA versus Addition of Omalizumab on Transcriptomic Expression Profiles in Patients with Allergic Asthma
by: Liang YR, et al.
Published: (2025-06-01)

Omalizumab controls surface phenotypes of dendritic cells and monocytes in asthma
by: Agnes Yang, BS, et al.
Published: (2025-08-01)

Hypertrophic and polypose changes in the synonasal mucosa in children with atopic bronchial asthma and allergic rhinitis
by: N. I. Eruslankin, et al.
Published: (2023-03-01)

Effectiveness and pharmacoeconomic analysis of the treatment of severe asthma with omalizumab in clinical practice
by: Eva Martínez-Moragón, et al.
Published: (2019-05-01)

Assessing the Quality of Life Using the Health Utilities Index Questionnaire in Children With Severe Persistent Asthma During the Treatment With Omalizumab
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-12-01)

Pilot Project «All-Russian Registry of Patients with Severe Bronchial Asthma.» The First Results in a Children’s Group of Patients (Moscow’s Observation Program)
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-08-01)

Airway hyperresponsiveness in bronchial asthma: pathogenesis basics
by: I. A. Deyev, et al.
Published: (2002-12-01)

FEATURES OF TRANSFORMATIONS OF RED BLOOD CELLS IN CHILDREN WITH BRONCHIAL ASTHMA
by: E. N. Suprun, et al.
Published: (2017-12-01)

CLINICAL-IMMUNOLOGICAL EFFECTIVENESS OF RIBOMUNYL IN CHILDREN WITH VIRUS-INDUCED BRONCHIAL ASTHMA
by: E. B. Belan, et al.
Published: (2020-12-01)

The role of immunological biomarkers in the pathogenesis of atopic bronchial asthma
by: T. T. Panahova
Published: (2025-05-01)

CLINICAL IMMUNOLOGICAL PECULIARATIES OF ATOPIC BRONCHIAL ASTHMA DEPENDING FROM THE LEVEL OF CONTROL OVER THE DISEASE IN CHILDREN
by: O. S. Tyutina, et al.
Published: (2012-05-01)

CYTOKINE GENES AS GENETIC MARKERS OF CONTROLLED AND UNCONTROLLED ATOPIC BRONCHIAL ASTHMA
by: M. V. Smolnikova, et al.
Published: (2017-10-01)

Real-world clinical utility (effectiveness) of omalizumab as add-on therapy in patient with difficult-to-treat severe allergic asthma
by: Rowshne Jahan, et al.
Published: (2025-01-01)

Health care resource utilization of patients with asthma and food allergy initiating omalizumab
by: John A. Bird, MD, et al.
Published: (2025-08-01)

Quality of life in patients having severe bronchial asthma
by: T. V. Smetanenko, et al.
Published: (2005-12-01)

Efficacy of ABC-X model care intervention combined with omalizumab on moderate to severe allergic asthma and negative emotional of family members
by: ZHAO Nina, et al.
Published: (2024-06-01)

Problem of comorbidity in patients with bronchial asthma
by: D. V. Ushakova, et al.
Published: (2021-06-01)

Clinical Significance of Melatonin in Bronchial Asthma
by: А. V. Budnevskiy, et al.
Published: (2022-02-01)

Modern Understanding of Severe Bronchial Asthma
by: A. Yu. Kraposhina, et al.
Published: (2022-03-01)

Cytokines and nitric oxide in case of bronchial asthma
by: F. I. Petrovsky, et al.
Published: (2002-03-01)

Bronchial Asthma and COVID-19: Comorbidity Issues
by: E. S. Ovsyannikov, et al.
Published: (2021-09-01)

Bronchial Thermoplasty in the Treatment of Asthma A Literature Review
by: Katarzyna Torbacka, et al.
Published: (2025-05-01)

Epithelial barrier dysfunction in bronchial asthma
by: R. N. Khramova, et al.
Published: (2022-09-01)

The role of periostin as an inflammatory marker in bronchial asthma in children
by: N. A. Belykh, et al.
Published: (2024-10-01)

SOME FEATURES OF CHANGING TELOMERE LENGTH IN LYMPHOCYTES FROM THE PATIENTS WITH BRONCHIAL ASTHMA
by: V. I. Borisov, et al.
Published: (2014-07-01)

PATHOGENETIC JUSTIFICATION AND EFFICIENCY OF MELATONIN APPLICATION IN PATIENTS WITH BRONCHIAL ASTHMA
by: G. I. Litvinenko, et al.
Published: (2014-07-01)

Bronchial asthma in the era of personalized medicine
by: A. Kh. Ibisheva, et al.
Published: (2025-01-01)